Clinical Trial Update: Safety, Tolerability, and Efficacy of Once Daily Amlodipine/Valsartan 5/80 as Compared to Amlodipine/Valsartan 5/40 or to Amlodipine 5 mg Monotherapy in Patients 65 Years of Age and Older With Essential Hypertension [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the safety, tolerability, and efficacy of once-daily amlodipine/valsartan 5/80 compared with amlodipine/valsartan 5/40 or amlodipine …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Exforge (valsartan; amlodipine)
• amlodipine 5 mg (amlodipine)
• amlodipine/valsartan 5/40 (amlodipine/valsartan)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2011-06-06